In their recent analysis
1
of tuberculosis within the U.S. military, Mancuso and colleagues demonstrate that
factors identifiable at application comprise the strongest risk for subsequent development
of active tuberculosis. Their findings imply that a significant burden of disease
within the U.S. military is due to pre-existing latent tuberculosis infection (LTBI)
among new recruits.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Preventive MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Active tuberculosis and recent overseas deployment in the U.S. military.Am J Prev Med. 2010; 39: 157-163
- Medical standards for appointment, enlistment, or induction in the military services (Instruction 6130.03).
- Pseudoepidemics of tuberculin skin test conversions in the U.S. Army after recent deployments.Am J Respir Crit Care Med. 2008; 177: 1285-1289
- Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection—United States, 2010.MMWR Recomm Rep. 2010; 59: 1-25
- A comparison of the military entrance processing station screening audiogram with the Defense Occupational and Environmental Health Readiness System reference audiogram at Fort Sill, Oklahoma, in 2000.Mil Med. 2006; 171: 117-121
- Cost-effective syphilis screening in military recruit applicants.Mil Med. 1999; 164: 580-584
- Fulfilling the military service obligation (Instruction 1304.25).
Article info
Identification
Copyright
Published by Elsevier Inc.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Response from the AuthorsAmerican Journal of Preventive MedicineVol. 39Issue 6
- PreviewWe would like to clarify some specific scientific and military issues raised by Dr. Nevin's response to our article.1 These issues include the thesis that switching from the use of the tuberculin skin test (TST) to an interferon-gamma release assay (IGRA) will improve adherence to therapy in the military's universal latent tuberculosis infection (LTBI) screening program and the thesis that the IGRA would be more cost effective than the TST in military populations.
- Full-Text
- Preview
